Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells.
Zancan, Patricia; Sola-Penna, Mauro; Furtado, Cristiane Marques; Da Silva, Daniel.
Mol Genet Metab
; 100(4): 372-8, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20483646
Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations.
Crystal structure of human platelet phosphofructokinase-1 locked in an activated conformation.
Phosphofructokinase type 1 kinetics, isoform expression, and gene polymorphisms in cancer cells.
Characterization of the pyrophosphate-dependent 6-phosphofructokinase from Xanthomonas campestris pv. campestris.
Phosphofructokinase-P Modulates P44/42 MAPK Levels in HeLa Cells.
Evidence That Does Not Support Pyruvate Kinase M2 (PKM2)-catalyzed Reaction as a Rate-limiting Step in Cancer Cell Glycolysis.
PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells.
Structure and allosteric regulation of eukaryotic 6-phosphofructokinases.
Enhancement of rapamycin production by metabolic engineering in Streptomyces hygroscopicus based on genome-scale metabolic model.
6-Phosphofructokinase and ribulose-5-phosphate 3-epimerase in methylotrophic Bacillus methanolicus ribulose monophosphate cycle.